Investing using the 'Rule of Numbers' method: Let's say

New Post Public Reply Private Reply Replies (0) Message Board
joey68
Investing using the 'Rule of Numbers' method:

Let's say Joe Bob has $1000 to invest in the market. Its not more than he can afford to lose, and any losses wouldn't affect his standard of living.

Joe Bob is somewhat new to investing but he wants to invest with the hopes of at least doubling his money.

Using the 'Rule of Numbers' method, Joe Bob would invest $900 in 9 different companies. Why $900 and not $1000? Simple. Fees. The average cost of each transaction is $10, so if he has $1000 to spend, $100 is actually paying for the purchase leaving him with $900 to invest.

You see, he could invest $990 in one company (minus $10 fee), hope for the best, and see where it goes. If it was a great investment, he could make a pretty good return on his initial investment.

But.. and theres a big 'but' here..


If he invested his entire balance in one stock, and that stock fails, does a reverse split, goes under, ends up being a pump and dump, etc etc.. he just lost $990 in one fell swoop.

On the other hand, with the 'Rule of Numbers' method, investing in 9 different companies allows room for error, poor DD, failed companies, etc etc.

Example:

Stock ABCD is selling at .0005. Joe Bob wants to invest his entire $990 in it. He has a great feeling. Lots of hype brewing in the investment forums online. People promising 'too the moon!'.

After fees, he would own 1,980,000 shares. Sounds great! To double his initial investment, the share price has to go to just over .001. Possible? Of course. anything is possible in the OTC.

On the other hand, if he invests $900 (minus fees) in 9 different companies and theyre all at .0003:

Each company would equate to 333,333 shares. In total, Joe Bob would own 2,999,997 shares; that's 1,019,997 MORE shares than if he invested in only one company for only $90 more.

See where I'm going with this?

Now lets say Joe Bob simply sucks at picking good stocks and 6 of his 9 investments fail leaving him with only 3 stocks which are about to move up:

Stock 1 goes from .0003 to .001. $333 profit
Stock 2 goes from .0003 to .005. $1,666 profit
Stock 3 goes from .0003 to .014. $4,666 profit

After selling, Joe Bob has $6,665 in his account.

Here's the best part:

Even though SIX of joe Bob's investments failed, he still was able to pull off a profit. Seeing he's not very good at picking good stocks, which scenario do you think is better for him?.. Invest everything in ONE company? Or invest in several.

This method also makes the most of our time. Instead of investing in one company and waiting for PR's and updates, by investing in several companies with several different time tables, it affords us the opportunity to possibly experience more PR's and progress for the same amount of time.

Obviously, the 'Rule of Numbers' method doesn't guarantee profits. All 9 companies could fail. Anything can happen in the stock market. But by doing DD, heavily researching each company, contacting the companies and asking questions, by NOT investing more than he can afford to lose, and by investing in more than one company, he provides himself a cushion.

Note:
All of these numbers are examples. It would work by investing in two companies instead of just one. That's the great thing about investing. It can be tailored to our individual needs and resources.

Note2:
I believe many investors do not want to take the time to research several companies and would rather risk their entire investment in one stock.

Not investment advice. Investing is RISKY and you can LOSE IT ALL IN A SINGLE DAY!!
View My Board Here:
http://investorshangout.com/Joeys-Investment-Board-91611/


Invite Only

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.

Disclaimer:
As used herein, the terms "You" and "Your" shall mean you, individually, the reader, and each other party on whose behalf you may use the contained information at any time.
All references to "My", "I", and “The writer of the above post” shall refer to the creator of the username Joey68.

Do NOT invest unless you are prepared to sustain a total loss of the money you have invested plus any commission or other transaction charges.

There is a very high degree of risk involved in trading and investing. Past results are not indicative of future returns. I assume no responsibility for your trading and investment results. You should NOT rely on the information in the above post to make any decision or take any action.

ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are OPINION and NOT fact and are for entertainment purposes only. Do your own research and make your own decisions based on your own conclusions.
ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are NOT advice, and are NOT designed to substitute the expertise and judgment of a professional. It is your responsibility to seek investment advice during all stages of your investments. It is your responsibility to evaluate the accuracy, completeness and usefulness of the information in the above post.
I am NOT a professional.
I do NOT work for you.
My posts are NOT investment advice. I am not paid to post.
There is no correlation between the number of posts I write per day and your assumed success of a company.
It is NOT my responsibility to inform you of my own personal investment decisions.
It is NOT my responsibility to inform you when it is time for you to buy, hold, and/or sell a position.
I have no control over, and am not responsible for the actions of others who copy, store, edit, change, prepare any derivative work of or alter in any way any of the content provided in my posts.
Errors and Omissions expected. The writer of the above post accepts no liability or responsibility for any errors or omissions contained in the above post or contained within this Disclaimer.
The writer of the above post shall NOT accept any liability for the accuracy or completeness of the information contained in the above post, for any reliance placed by any person on the information contained in the above post, or for any damage or loss, however caused, in connection with the use or reliance on any information contained in the above post.
The above post may contain links to websites owned and operated by third parties. These links are provided for informational purposes only and are NOT endorsed by the writer of the above post. The writer of the above post has no control over the contents of any linked website and bears no responsibility for the accuracy, legality, or content of the external site or for that of subsequent links.
YOU ACCESS ALL LINKS ENTIRELY AT YOUR OWN RISK.
The writer of the above post makes no warranties or representations, express or implied about such linked websites, the third parties they are owned and operated by, or the information contained on these websites.
The writer of the above post accepts no liability for any damage or loss, however caused, in connection with the use of or reliance on any information, material, products, or services contained on or accessed through any such linked websites.

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

ZEISS Expands in China: Tackling Myopia's Surge

Updated Category News Views 157

ZEISS Sets Sights on China’s Myopia Epidemic They're calling myopia a public health crisis in China, and if you've seen the statistics, that's no exaggeration. Enter ZEISS Medical Technology, angling for a piece of the pie with their newly NMPA-approved PT LUNANA phakic intraocular lens. This is more than just another medical product, folks. It's a strategic entry into...

Continue Reading
Keenova Q3 2026: Net Sales Up, Losses Shrink

Updated Category News Views 29

A Strong Quarter Despite Some Knocks It ain't every day you see a company like Keenova Therapeutics clocking solid top-line growth, despite battling the waves of operational losses. Now, don't get me wrong; I ain't swooning over their near $96 million loss from continuing operations, but let me give credit where it's due—those sales numbers popped impressive. Pillars of...

Continue Reading
First Graphene Taps Deeper into US Defense Market

Updated Category News Views 109

Graphene Making Waves in Defense Fresh off the press, folks. First Graphene Limited is struttin' onto the US defense scene with a repeat order for its PureGRAPH®—a big deal in the realm of electrically conductive inks. The tally comes to around A$35,000 in an order from a longtime American customer. We're talking about inks that print circuits, sensors, and more,...

Continue Reading
Grandparents' Holiday Gift Picks: Expertly Tested Ideas

Updated Category News Views 21

Hunting for the Perfect Gift? Look No Further The holiday hustle and bustle inevitably sparks one of the annual dilemmas: What on earth should you buy those grandkids of yours? No need to get all twisted up this season. Enter ZestYears, the savvy go-to guide for grandparents who want to nail gift-giving without breaking a sweat or the bank. These folks, based out of...

Continue Reading
Kelley Blue Book Hits 100: Celebrating on Route 66

Updated Category News Views 36

If you've ever punched numbers on car values, you've probably bumped into Kelley Blue Book. This icon in vehicle valuation is marking its 100th birthday with a bang—road-tripping across Route 66 to sprinkle some joy across the dusty roads of history. Nostalgia Meets the Open Road The legendary Route 66 is not just the backdrop but the beating heart of this centennial...

Continue Reading
Tampa General Tackles Housing with The Linden Launch

Updated Category News Views 93

Building Bridges Between Work and Home Well, it’s about time someone threw in a lifeline to those drowning in Florida’s housing crisis. Tampa General Hospital, teaming up with The Michaels Organization, is setting the stage with 'The Linden': a solution pitched smack dab into the heart of affordability woes. This isn't your run-of-the-mill press release fluff. They've...

Continue Reading
Hexnode XDR Expands Threat Detection, MacOS Support

Updated Category News Views 24

Hexnode XDR: A Game Changer for MacOS Threats Ever heard of Hexnode? Well, today's chat is all about them beefing up their XDR platform. They’ve sagely added support for macOS—finally given the platform some love alongside Windows. It's about time! This move is a big win for everyone whose daily grind depends on keeping threats at bay across platforms. We’re talking...

Continue Reading
Caladan and NextBlock's Move Expands Crypto Liquidity

Updated Category News Views 55

Partnership to Expand Digital Asset Liquidity Looks like Caladan and NextBlock just threw their hats in the ring to shake up South Korea’s institutional digital asset market. These two big guns have cooked up a strategic collaboration, aiming to bring more global liquidity into the mix. Dive into what this means for the digital asset scene in South Korea. Why This Move...

Continue Reading
Giti Tire Hits Jaw-Dropping Speeds with Record-Breaker

Updated Category News Views 78

Blazing a New Trail in Automotive Excellence Who would've thought rubber on road could hit a jaw-dropping 503.17 km/h (312.65 mph)? Giti Tire just broke the mold, etching its name into the history books with the Guinness World Records™ title for their GitiSport e.GTR2 Pro tires. This isn't just about speed—it's about engineering marvel and pushing boundaries in...

Continue Reading
Blurry Vision Explained: Beyond Just a Lens Issue

Updated Category News Views 81

Why Your Vision Might Be Blurry: It's Not Always Simple Dr. Spencer Franz isn’t just another face behind an optometry chart. He’s tackling a topic as blurry as it is relatable—your vision. You'd think a simple tweak of your glasses script might do the trick, but surprise, surprise, vision issues are sneakier than that. Changes in prescriptions are a dime a dozen,...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Cresco Labs: A Unique Investment Opportunity

Updated Category News Views 158

Assessing Cresco Labs: A Promising Investment Prospect With the cannabis market continuing to evolve, Cresco Labs Inc. stands out as an intriguing option for investors. Despite a backdrop of flat earnings and ongoing market challenges, analysts emphasize that Cresco (CRLBF) is holding the line as an "Overweight" stock. A recent analysis reveals Cresco's substantial...

Continue Reading
Context Therapeutics' First Quarter 2025 Results and Updates

Updated Category News Views 249

Context Therapeutics Releases First Quarter 2025 Financial Results Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company, made significant strides in Q1 2025, especially with its two product candidates, CTIM-76 and CT-95, currently in Phase 1 clinical trials. As of March 31, 2025, the company reported...

Continue Reading
Capricor's Challenges: FDA Review Delays and Legal Woes

Updated Category News Views 70

Capricor Under the Spotlight: FDA and SEC Concerns Ah, Capricor Therapeutics, Inc. (NASDAQ: CAPR)—a tale of high stakes and even higher expectations now hanging by a very taut thread. Investors are feeling the heat as the U.S. Food and Drug Administration (FDA) presses pause on Capricor's plans, and the courtroom drama unfolds with a securities class action looming over...

Continue Reading
Breaking New Ground: Wood Partners Launches Alta Flatirons

Updated Category News Views 258

Wood Partners Begins Construction on Alta Flatirons The 251-unit apartment community is one of the last remaining parcels of the Downtown Superior Masterplan. Overview of Alta Flatirons National multifamily developer Wood Partners has officially commenced the development of Alta Flatirons, a significant project located in a suburb near Boulder. This community, which will...

Continue Reading
Adobe Unveils New AI Tools to Maximize Content Engagement

Updated Category News Views 86

Adobe Unveils Exciting New AI-Driven Marketing Tools Adobe Systems Incorporated (NASDAQ: ADBE) has just rolled out a game-changing suite of updates to its Adobe Experience Cloud services. These innovations are designed to help brands enhance the performance of their AI-generated marketing content significantly. With a focus on advanced analytics and the ability to...

Continue Reading